Latanoprost for Treatment of Ménière Disease: A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy of Intratympanic Management for Symptom Control
In this placebo-controlled study, latanoprost was not more effective than placebo in the treatment of MD and did not improve speech discrimination in noise, hearing, and tinnitus or vertigo symptoms.
Authors
- Ellen Lindell (ORCID: https://orcid.org/0000-0002-2168-3088)
- Cecilia Engmér Berglin (ORCID: https://orcid.org/0009-0003-1986-3818)
- Ylva Dahlin Redfors (ORCID: https://orcid.org/0000-0002-1234-6573)
- Tatjana Tomanovic (ORCID: https://orcid.org/0009-0001-5722-7893)
- B. E. Karlberg
Institutions
- Karolinska University Hospital (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- Södra Älvsborg Hospital (SE)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Otology & Neurotology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1097/mao.0000000000004732
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00